These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2300980)

  • 41. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
    Stoodley M; Weihl CC; Zhang ZD; Lin G; Johns LM; Kowalczuk A; Ghadge G; Roos RP; Macdonald RL
    Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myosin light chain phosphorylation and contractile proteins in a canine two-hemorrhage model of subarachnoid hemorrhage.
    Sun H; Kanamaru K; Ito M; Suzuki H; Kojima T; Waga S; Kureishi Y; Nakano T
    Stroke; 1998 Oct; 29(10):2149-54. PubMed ID: 9756597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm.
    Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H
    Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm.
    Vollmer DG; Kassell NF; Hongo K; Ogawa H; Tsukahara T
    Surg Neurol; 1989 Mar; 31(3):190-4. PubMed ID: 2922661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
    Gavras H; Andrews P; Papadakis N
    J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs.
    Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N
    J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report.
    Kistler JP; Lees RS; Candia G; Zervas NT; Crowell RM; Ojemann RG
    Stroke; 1979; 10(1):26-9. PubMed ID: 107621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.
    Ito Y; Isotani E; Mizuno Y; Azuma H; Hirakawa K
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):45-50. PubMed ID: 10630732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model.
    Nagata K; Sasaki T; Iwama J; Mori T; Iwamoto S; Nirei H; Hamada K; Kirino T
    J Neurosurg; 1993 Nov; 79(5):710-5. PubMed ID: 7692019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model.
    Yamaguchi-Okada M; Nishizawa S; Mizutani A; Namba H
    Cerebrovasc Dis; 2009; 28(2):135-42. PubMed ID: 19506373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage.
    Ohta S; Nishihara J; Oka Y; Todo H; Kumon Y; Sakaki S
    Acta Neurochir (Wien); 1995; 137(3-4):217-25. PubMed ID: 8789664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm.
    Nishizawa S; Yamamoto S; Yokoyama T; Ryu H; Uemura K
    Stroke; 1995 Oct; 26(10):1916-20; discussion 1920-1. PubMed ID: 7570748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid.
    Matsumura Y; Ikegawa R; Suzuki Y; Takaoka M; Uchida T; Kido H; Shinyama H; Hayashi K; Watanabe M; Morimoto S
    Life Sci; 1991; 49(11):841-8. PubMed ID: 1875792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707.
    Macdonald RL; Johns L; Lin G; Marton LS; Hallak H; Marcoux F; Kowalczuk A
    Neurol Med Chir (Tokyo); 1998; 38 Suppl():138-45. PubMed ID: 10234996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model.
    Kita T; Kubo K; Hiramatsu K; Sakaki T; Yonetani Y; Sato S; Fujimoto M; Nakashima T
    Life Sci; 1998; 63(4):305-15. PubMed ID: 9698039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic and metabolic effects of flunarizine in experimental subarachnoid hemorrhage in dogs.
    De Ley G; Eechaute W; Strijckmans K; Goethals P; Lemahieu I; Van de Velde E; Weyne J
    Stroke; 1993 Mar; 24(3):400-5; discussion 405-6. PubMed ID: 8446977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.